+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Emergency Contraceptive Pills Market 2023-2027

  • PDF Icon

    Report

  • 154 Pages
  • December 2022
  • Region: Global
  • TechNavio
  • ID: 5449062
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The emergency contraceptive pills market is forecasted to grow by $258.7 mn during 2022-2027, accelerating at a CAGR of 4.83% during the forecast period. Our report on the emergency contraceptive pills market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of initiatives to create awareness, increase in unplanned pregnancies, and ease of online purchase.

The emergency contraceptive pills market is segmented as below:

By Distribution Channel

  • Retail stores
  • Online stores

By Type

  • Combination pills
  • Progesterone pills

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the importance of family planning as one of the prime reasons driving the emergency contraceptive pills market growth during the next few years. Also, the advent of online apps and rising disposable income will lead to sizable demand in the market.

The report on the emergency contraceptive pills market covers the following areas:

  • Emergency contraceptive pills market sizing
  • Emergency contraceptive pills market forecast
  • Emergency contraceptive pills market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading emergency contraceptive pills market vendors that include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd. Also, the emergency contraceptive pills market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global emergency contraceptive pills market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global emergency contraceptive pills market 2017 - 2021 ($ million)
4.2 Distribution channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Retail stores - Market size and forecast 2022-2027
Exhibit 34: Chart on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Retail stores - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Retail stores - Year-over-year growth 2022-2027 (%)
6.4 Online stores - Market size and forecast 2022-2027
Exhibit 38: Chart on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Online stores - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Online stores - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 43: Chart on Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 45: Chart on Comparison by Type
Exhibit 46: Data Table on Comparison by Type
7.3 Combination pills - Market size and forecast 2022-2027
Exhibit 47: Chart on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Combination pills - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Combination pills - Year-over-year growth 2022-2027 (%)
7.4 Progesterone pills - Market size and forecast 2022-2027
Exhibit 51: Chart on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Progesterone pills - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Progesterone pills - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 81: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 104: AbbVie Inc. - Overview
Exhibit 105: AbbVie Inc. - Product / Service
Exhibit 106: AbbVie Inc. - Key news
Exhibit 107: AbbVie Inc. - Key offerings
12.4 Afaxys Pharma LLC
Exhibit 108: Afaxys Pharma LLC - Overview
Exhibit 109: Afaxys Pharma LLC - Product / Service
Exhibit 110: Afaxys Pharma LLC - Key offerings
12.5 Bayer AG
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key news
Exhibit 114: Bayer AG - Key offerings
Exhibit 115: Bayer AG - Segment focus
12.6 Combe Inc.
Exhibit 116: Combe Inc. - Overview
Exhibit 117: Combe Inc. - Product / Service
Exhibit 118: Combe Inc. - Key offerings
12.7 Foundation Consumer Healthcare LLC
Exhibit 119: Foundation Consumer Healthcare LLC - Overview
Exhibit 120: Foundation Consumer Healthcare LLC - Product / Service
Exhibit 121: Foundation Consumer Healthcare LLC - Key offerings
12.8 Gedeon Richter Plc
Exhibit 122: Gedeon Richter Plc - Overview
Exhibit 123: Gedeon Richter Plc - Business segments
Exhibit 124: Gedeon Richter Plc - Key news
Exhibit 125: Gedeon Richter Plc - Key offerings
Exhibit 126: Gedeon Richter Plc - Segment focus
12.9 HLL Lifecare Ltd.
Exhibit 127: HLL Lifecare Ltd. - Overview
Exhibit 128: HLL Lifecare Ltd. - Product / Service
Exhibit 129: HLL Lifecare Ltd. - Key offerings
12.10 Laboratoire HRA Pharma SAS
Exhibit 130: Laboratoire HRA Pharma SAS - Overview
Exhibit 131: Laboratoire HRA Pharma SAS - Product / Service
Exhibit 132: Laboratoire HRA Pharma SAS - Key offerings
12.11 Lupin Ltd.
Exhibit 133: Lupin Ltd. - Overview
Exhibit 134: Lupin Ltd. - Product / Service
Exhibit 135: Lupin Ltd. - Key news
Exhibit 136: Lupin Ltd. - Key offerings
12.12 Mankind Pharma Ltd.
Exhibit 137: Mankind Pharma Ltd. - Overview
Exhibit 138: Mankind Pharma Ltd. - Product / Service
Exhibit 139: Mankind Pharma Ltd. - Key offerings
12.13 Perrigo Co. Plc
Exhibit 140: Perrigo Co. Plc - Overview
Exhibit 141: Perrigo Co. Plc - Business segments
Exhibit 142: Perrigo Co. Plc - Key news
Exhibit 143: Perrigo Co. Plc - Key offerings
Exhibit 144: Perrigo Co. Plc - Segment focus
12.14 Pfizer Inc.
Exhibit 145: Pfizer Inc. - Overview
Exhibit 146: Pfizer Inc. - Product / Service
Exhibit 147: Pfizer Inc. - Key news
Exhibit 148: Pfizer Inc. - Key offerings
12.15 Piramal Enterprises Ltd.
Exhibit 149: Piramal Enterprises Ltd. - Overview
Exhibit 150: Piramal Enterprises Ltd. - Business segments
Exhibit 151: Piramal Enterprises Ltd. - Key offerings
Exhibit 152: Piramal Enterprises Ltd. - Segment focus
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 155: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Syzygy Healthcare LLC
Exhibit 156: Syzygy Healthcare LLC - Overview
Exhibit 157: Syzygy Healthcare LLC - Product / Service
Exhibit 158: Syzygy Healthcare LLC - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 159: Inclusions checklist
Exhibit 160: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 161: Currency conversion rates for US$
13.4 Research methodology
Exhibit 162: Research methodology
Exhibit 163: Validation techniques employed for market sizing
Exhibit 164: Information sources
13.5 List of abbreviations
Exhibit 165: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global emergency contraceptive pills market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Retail stores - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Retail stores - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Online stores - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Online stores - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Distribution Channel ($ million)
Exhibits 43: Chart on Type - Market share 2022-2027 (%)
Exhibits 44: Data Table on Type - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Type
Exhibits 46: Data Table on Comparison by Type
Exhibits 47: Chart on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Combination pills - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Combination pills - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Progesterone pills - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Progesterone pills - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by Type ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 97: Market opportunity By Geographical Landscape ($ million)
Exhibits 98: Impact of drivers and challenges in 2022 and 2027
Exhibits 99: Overview on Criticality of inputs and Factors of differentiation
Exhibits 100: Overview on factors of disruption
Exhibits 101: Impact of key risks on business
Exhibits 102: Vendors covered
Exhibits 103: Matrix on vendor position and classification
Exhibits 104: AbbVie Inc. - Overview
Exhibits 105: AbbVie Inc. - Product / Service
Exhibits 106: AbbVie Inc. - Key news
Exhibits 107: AbbVie Inc. - Key offerings
Exhibits 108: Afaxys Pharma LLC - Overview
Exhibits 109: Afaxys Pharma LLC - Product / Service
Exhibits 110: Afaxys Pharma LLC - Key offerings
Exhibits 111: Bayer AG - Overview
Exhibits 112: Bayer AG - Business segments
Exhibits 113: Bayer AG - Key news
Exhibits 114: Bayer AG - Key offerings
Exhibits 115: Bayer AG - Segment focus
Exhibits 116: Combe Inc. - Overview
Exhibits 117: Combe Inc. - Product / Service
Exhibits 118: Combe Inc. - Key offerings
Exhibits 119: Foundation Consumer Healthcare LLC - Overview
Exhibits 120: Foundation Consumer Healthcare LLC - Product / Service
Exhibits 121: Foundation Consumer Healthcare LLC - Key offerings
Exhibits 122: Gedeon Richter Plc - Overview
Exhibits 123: Gedeon Richter Plc - Business segments
Exhibits 124: Gedeon Richter Plc - Key news
Exhibits 125: Gedeon Richter Plc - Key offerings
Exhibits 126: Gedeon Richter Plc - Segment focus
Exhibits 127: HLL Lifecare Ltd. - Overview
Exhibits 128: HLL Lifecare Ltd. - Product / Service
Exhibits 129: HLL Lifecare Ltd. - Key offerings
Exhibits 130: Laboratoire HRA Pharma SAS - Overview
Exhibits 131: Laboratoire HRA Pharma SAS - Product / Service
Exhibits 132: Laboratoire HRA Pharma SAS - Key offerings
Exhibits 133: Lupin Ltd. - Overview
Exhibits 134: Lupin Ltd. - Product / Service
Exhibits 135: Lupin Ltd. - Key news
Exhibits 136: Lupin Ltd. - Key offerings
Exhibits 137: Mankind Pharma Ltd. - Overview
Exhibits 138: Mankind Pharma Ltd. - Product / Service
Exhibits 139: Mankind Pharma Ltd. - Key offerings
Exhibits 140: Perrigo Co. Plc - Overview
Exhibits 141: Perrigo Co. Plc - Business segments
Exhibits 142: Perrigo Co. Plc - Key news
Exhibits 143: Perrigo Co. Plc - Key offerings
Exhibits 144: Perrigo Co. Plc - Segment focus
Exhibits 145: Pfizer Inc. - Overview
Exhibits 146: Pfizer Inc. - Product / Service
Exhibits 147: Pfizer Inc. - Key news
Exhibits 148: Pfizer Inc. - Key offerings
Exhibits 149: Piramal Enterprises Ltd. - Overview
Exhibits 150: Piramal Enterprises Ltd. - Business segments
Exhibits 151: Piramal Enterprises Ltd. - Key offerings
Exhibits 152: Piramal Enterprises Ltd. - Segment focus
Exhibits 153: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 154: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 155: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 156: Syzygy Healthcare LLC - Overview
Exhibits 157: Syzygy Healthcare LLC - Product / Service
Exhibits 158: Syzygy Healthcare LLC - Key offerings
Exhibits 159: Inclusions checklist
Exhibits 160: Exclusions checklist
Exhibits 161: Currency conversion rates for US$
Exhibits 162: Research methodology
Exhibits 163: Validation techniques employed for market sizing
Exhibits 164: Information sources
Exhibits 165: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global emergency contraceptive pills market: AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is importance of family planning.`

According to the report, one of the major drivers for this market is the rise in number of initiatives to create awareness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Bayer AG
  • Combe Inc.
  • Foundation Consumer Healthcare LLC
  • Gedeon Richter Plc
  • HLL Lifecare Ltd.
  • Knoll Healthcare Pvt. Ltd.
  • Laboratoire HRA Pharma SAS
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Morepen Laboratories Ltd.
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Syzygy Healthcare LLC
  • Teva Pharmaceutical Industries Ltd.